Beijing Konruns Pharmaceutical Co.,Ltd. (SHA:603590)
China · Delayed Price · Currency is CNY 36.86
+0.90 (2.50%)
Jul 15, 2026, 3:00 PM CST
SHA:603590 Market Cap
SHA:603590 has a market cap or net worth of 5.66 billion as of July 14, 2026. Its market cap has increased by 17.62% in one year.
Market Cap
5.66B
Enterprise Value
5.49B
Revenue
917.99M
Ranking
n/a
PE Ratio
33.94
Stock Price
36.86
Market Cap Chart
Since August 27, 2018, SHA:603590's market cap has increased from 5.61B to 5.66B, an increase of 1.02%. That is a compound annual growth rate of 0.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 5.66B | -10.37% |
| Dec 31, 2025 | 6.32B | 69.72% |
| Dec 31, 2024 | 3.72B | -37.51% |
| Dec 29, 2023 | 5.96B | 52.69% |
| Dec 30, 2022 | 3.90B | -23.24% |
| Dec 31, 2021 | 5.08B | -12.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wuhan Keqian Biology Co.,Ltd | 5.96B |
| PharmaResources (Shanghai) | 5.52B |
| Hangzhou Biotest Biotech | 5.44B |
| Novogene | 5.19B |
| R&G PharmaStudies | 4.91B |
| Shenzhen Weiguang Biological Products | 4.72B |
| Hefei Lifeon Pharmaceutical | 4.70B |
| Zhejiang Wecome Pharmaceutical Company | 4.69B |